Luis Enjuanes
Affiliations: | Virology | Centro Nacional de Biotecnología CNB-CSIC |
Google:
"Luis Enjuanes"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Miguel Medina | post-doc | 1992-1992 | Centro Nacional de Biotecnología CNB-CSIC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| García-Crespo C, de Ávila AI, Gallego I, et al. (2024) Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture. British Journal of Pharmacology |
| Wang L, Guzman M, Muñoz-Santos D, et al. (2023) Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis. Frontiers in Cellular and Infection Microbiology. 13: 1268227 |
| Alhammad YM, Parthasarathy S, Ghimire R, et al. (2023) SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice. Proceedings of the National Academy of Sciences of the United States of America. 120: e2302083120 |
| Hurtado-Tamayo J, Requena-Platek R, Enjuanes L, et al. (2023) Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. Frontiers in Cellular and Infection Microbiology. 13: 1166839 |
| Alhammad YM, Parthasarathy S, Ghimire R, et al. (2023) SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice. Biorxiv : the Preprint Server For Biology |
| Somovilla P, García-Crespo C, Martínez-González B, et al. (2023) Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin. Antimicrobial Agents and Chemotherapy. 67: e0131522 |
| Enjuanes L, Sola I, Zúñiga S, et al. (2022) Nature of viruses and pandemics: Coronaviruses. Current Research in Immunology. 3: 151-158 |
| Martínez-González B, Soria ME, Vázquez-Sirvent L, et al. (2022) SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations. Pathogens (Basel, Switzerland). 11 |
| Martínez-González B, Soria ME, Vázquez-Sirvent L, et al. (2022) SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes. Microbiology Spectrum. 10: e0022122 |
| Malicoat J, Manivasagam S, Zuñiga S, et al. (2021) Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories. Journal of Virology. JVI0183721 |